We are live on ! Find out more
PSC

Patient Square Capital Portfolio holdings

AUM $564M
1-Year Est. Return 261.3%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+261.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$564M
AUM Growth
+$96.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$19.6M
2
+$18.9M
3
+$12M
4
COGT icon
Cogent Biosciences
COGT
+$10.3M
5
MRK icon
Merck
MRK
+$9.24M

Top Sells

1
+$16.8M
2
+$12.9M
3
+$7.83M
4
MIRM icon
Mirum Pharmaceuticals
MIRM
+$6.46M
5
OCUL icon
Ocular Therapeutix
OCUL
+$5.95M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTMX icon
26
CytomX Therapeutics
CTMX
$642M
$5.1M 0.91%
+1,085,790
RCUS icon
27
Arcus Biosciences
RCUS
$3.06B
$4.21M 0.75%
195,000
+25,000
ASMB icon
28
Assembly Biosciences
ASMB
$484M
$3.78M 0.67%
136,315
+9,315
SYRE icon
29
Spyre Therapeutics
SYRE
$7.67B
$50.4K 0.01%
1,000
-149,000
OCUL icon
30
Ocular Therapeutix
OCUL
$2.06B
– –
-490,000
TERN
31
DELISTED
Terns Pharmaceuticals
TERN
– –
-320,000
AMLX icon
32
Amylyx Pharmaceuticals
AMLX
$1.74B
– –
-350,000
AVTX icon
33
Avalo Therapeutics
AVTX
$773M
– –
-311,966
IRON icon
34
Disc Medicine
IRON
$2.7B
– –
-74,000
LQDA icon
35
Liquidia Corp
LQDA
$6.32B
– –
-227,000
1
2